A novel treatment for patients with hereditary haemorrhagic telangiectasia.
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walled vessels involved it is often refractory to conventional forms of treatment. We present the case of an 82-year-old lady with intractable epistaxis secondary to HHT, that was successfully controlled by the application of fibrin glue.
Farnan
T B
TB
Department of Otolaryngology, Antrim Area Hospital, Antrim, Northern Ireland, UK. turlough.farnan@ntlworld.com
Gallagher
G
G
Scally
C M
CM
D000368:Aged; D000369:Aged, 80 and over; D004844:Epistaxis / Q000209:etiology / Q000628:therapy*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use*; D006801:Humans; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications*; D014014:Tissue Adhesives / Q000627:therapeutic use*
D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives